Hyperuricemia May Be Related to Contrast-induced Nephropathy After Percutaneous Coronary Intervention
Overview
Overview
Journal
Clinics (Sao Paulo)
Publisher
Elsevier
Specialty
General Medicine
Date
2013 Aug 7
PMID
23917676
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Herzog C
. Kidney disease in cardiology. Nephrol Dial Transplant. 2008; 24(1):34-7.
DOI: 10.1093/ndt/gfn637.
View
2.
Toprak O
. Conflicting and new risk factors for contrast induced nephropathy. J Urol. 2007; 178(6):2277-83.
DOI: 10.1016/j.juro.2007.08.054.
View
3.
Matsushita K, Selvin E, Bash L, Astor B, Coresh J
. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2010; 55(4):648-59.
PMC: 2858455.
DOI: 10.1053/j.ajkd.2009.12.016.
View
4.
Balta S, Cakar M, Demirkol S, Balta I, Kurt O
. Re: Effect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease. Iran J Kidney Dis. 2013; 7(2):166-7.
View
5.
Fu N, Li X, Yang S, Chen Y, Li Q, Jin D
. Risk score for the prediction of contrast-induced nephropathy in elderly patients undergoing percutaneous coronary intervention. Angiology. 2012; 64(3):188-94.
DOI: 10.1177/0003319712467224.
View